from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3548c/-

LFCtreatmentdescriptionclass of inhibitor

-0.341

Amikacinug/mL Amikacintranslation

0.860

Cap5-10ug/mL Capreomycintranslation

1.458

Rox10-50 ug/mL Roxithromycintranslation

-0.267

SM2-5 ug/mL Streptomycintranslation

0.930

Tet5-10 ug/mL Tetracyclinetranslation

0.156

Rif0.2-5ug/mL Rifampicintranscription

-0.105

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.122

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.756

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.097

CPZ10-50 ug/mL Chlorpromazinerespiration

0.405

Clofazimine10-13 ug/mL Clofaziminerespiration

0.080

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.225

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.435

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.032

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.338

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.780

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.366

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.585

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.136

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.416

KCN5-20 ug/mL Potassium cyaniderespiration

-0.879

NaN30.2-2 mM Sodium aziderespiration

-0.671

Nigericin50 uM Nigericinrespiration

1.803

TRC10-150 ug/mL Triclosanrespiration

0.138

TRZ10-25 ug/mL Thioridazinerespiration

1.186

Valinomycin0.5-10 uM Valinomycinrespiration

-3.481

ZnSO42 mM ZnSO4respiration

-0.756

menadione6-10 ug/mL Menadionerespiration

1.148

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.635

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.233

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.838

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.487

NRP_1Non-replicating persistence stage 1dosRassociated

-0.840

Amp0.2mg/mL AmpicillincellWall

-0.564

Cephalexin20-100 ug/mL CephalexincellWall

-0.464

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.359

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.491

EMB10-20 ug/mL EthambutolcellWall

-0.012

Eta12-40 ug/mL EthionamidecellWall

-0.353

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.289

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.239

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.199

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.554

BZA0.12 mg/mL BenzamidearomaticAmides

0.325

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.233

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.099

H2O24 mM hydrogen peroxideDNAdamaging

-0.768

Levo10 ug/mL LevofloxacinDNAdamaging

-0.495

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.005

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.278

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.696

UVUV-irradiationDNAdamaging

-0.129

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.103

Antimycin12.5-50 ug/mL Antimycin A?

-0.057

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.118

PA_110-50 ug/mL Antitubercular compound PA-1?

0.055

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.178

PA8240.2-2 ug/mL PA-824?

1.039

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.443

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.190

Verapamil50 uM Verapamil?

-0.545

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.562

methoxatin10-20 ug/mL Methoxatin?